The role of apoptosis in the pathology of pancreatic cancer

Cancers

Volumn 3, Issue 1, 2011, Pages 1-16

  Samm, Nicole ^a   Werner, Kristin ^a   Rückert, Felix ^a   Saeger, Hans Detlev ^a   Grützmann, Robert ^a   Pilarsky, Christian ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Apoptosis; Pancreatic cancer; Signal transduction pathway

Indexed keywords

CASPASE; DEATH RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CARCINOGENESIS; CELL DEATH; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; MOLECULAR PATHOLOGY; PANCREAS CANCER; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 79953720289     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010001     Document Type: Review

References (93)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225-249.
2. Schneider, G.; Siveke, J.T.; Eckel, F.; Schmid, R.M. Pancreatic cancer: Basic and clinical aspects. Gastroenterology 2005, 128, 1606-1625.
3. Baer, H.U.; Wagner, M.; Sadowski, C.; Buchler, M.W. Pancreatic carcinoma: Surgical therapy. Ther. Umsch. 1996, 53, 394-400.
4. Luqmani, Y.A. Mechanisms of drug resistance in cancer chemotherapy. Med. Princ. Pract. 2005, 14 (Suppl. 1), 35-48.
5. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
6. Vogt, C. Untersuchungen über die Entwicklungsgeschichte der Geburtshelferkröte (alytes obstetricians). Jent und Gassman: Solothurn, Switzerland, 1842.
7. Kerr, J.F.; Wyllie, A.H.; Currie, A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
8. Kerr, J.F.; Winterford, C.M.; Harmon, B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994, 73, 2013-2026.
9. Fulda, S. Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J. Cell. Mol. Med. 2009, 13, 1221-1227.
10. Cotter, T.G. Apoptosis and cancer: The genesis of a research field. Nat. Rev. Cancer 2009, 9, 501-507.
11. Castedo, M.; Perfettini, J.L.; Roumier, T.; Andreau, K.; Medema, R.; Kroemer, G. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004, 23, 2825-2837.
12. Hengartner, M.O. The biochemistry of apoptosis. Nature 2000, 407, 770-776.
13. Van Cruchten, S.; Van Den Broeck, W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat. Histol. Embryol. 2002, 31, 214-223.
14. Rao, R.V.; Hermel, E.; Castro-Obregon, S.; del Rio, G.; Ellerby, L.M.; Ellerby, H.M.; Bredesen, D.E. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 2001, 276, 33869-33874.
15. Nawrocki, S.T.; Carew, J.S.; Pino, M.S.; Highshaw, R.A.; Dunner, K., Jr.; Huang, P.; Abbruzzese, J.L.; McConkey, D.J. Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res. 2005, 65, 11658-11666.
16. Ellgaard, L.; Helenius, A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell. Biol. 2003, 4, 181-191.
17. Nawrocki, S.T.; Carew, J.S.; Pino, M.S.; Highshaw, R.A.; Andtbacka, R.H.; Dunner, K., Jr.; Pal, A.; Bornmann, W.G.; Chiao, P.J.; Huang, P.; Xiong, H.; Abbruzzese, J.L.; McConkey, D.J. Aggresome disruption: A novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells. Cancer Res. 2006, 66, 3773-3781.
18. Hitomi, J.; Katayama, T.; Eguchi, Y.; Kudo, T.; Taniguchi, M.; Koyama, Y.; Manabe, T.; Yamagishi, S.; Bando, Y.; Imaizumi, K.; Tsujimoto, Y.; Tohyama, M. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and abeta-induced cell death. J. Cell. Biol. 2004, 165, 347-356.
19. Werner, K.; Rueckert, F.; Saeger, H.-D.; Gruetzmann, R.; Pilarsky, C. Recent patents concerning therapeutic applications against the apoptosis resistance of pancreatic cancer. Recent Pat. DNA Gene seq. 2010, submitted.
20. Hamacher, R.; Schmid, R.M.; Saur, D.; Schneider, G. Apoptotic pathways in pancreatic ductal adenocarcinoma. Mol. Cancer 2008, 7, 64.
21. Nagata, S. Apoptosis by death factor. Cell 1997, 88, 355-365.
22. Fulda, S.; Debatin, K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25, 4798-4811.
23. Kornmann, M.; Ishiwata, T.; Kleeff, J.; Beger, H.G.; Korc, M. Fas and fas-ligand expression in human pancreatic cancer. Ann. Surg. 2000, 231, 368-379.
24. Elnemr, A.; Ohta, T.; Yachie, A.; Kayahara, M.; Kitagawa, H.; Fujimura, T.; Ninomiya, I.; Fushida, S.; Nishimura, G.I.; Shimizu, K.; Miwa, K. Human pancreatic cancer cells disable function of fas receptors at several levels in fas signal transduction pathway. Int. J. Oncol. 2001, 18, 311-316.
25. Ungefroren, H.; Voss, M.; Bernstorff, W.V.; Schmid, A.; Kremer, B.; Kalthoff, H. Immunological escape mechanisms in pancreatic carcinoma. Ann. N. Y. Acad. Sci. 1999, 880, 243-251.
26. Ungefroren, H.; Kruse, M.L.; Trauzold, A.; Roeschmann, S.; Roeder, C.; Arlt, A.; Henne-Bruns, D.; Kalthoff, H. Fap-1 in pancreatic cancer cells: Functional and mechanistic studies on its inhibitory role in cd95-mediated apoptosis. J. Cell Sci. 2001, 114, 2735-2746.
27. Scaffidi, C.; Fulda, S.; Srinivasan, A.; Friesen, C.; Li, F.; Tomaselli, K.J.; Debatin, K.M.; Krammer, P.H.; Peter, M.E. Two cd95 (apo-1/fas) signaling pathways. EMBO J. 1998, 17, 1675-1687.
28. Ruckert, F.; Dawelbait, G.; Winter, C.; Hartmann, A.; Denz, A.; Ammerpohl, O.; Schroeder, M.; Schackert, H.K.; Sipos, B.; Kloppel, G.; Kalthoff, H.; Saeger, H.D.; Pilarsky, C.; Grutzmann, R. Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis. PLoS One 2010, 5, e12243.
29. Grutzmann, R.; Pilarsky, C.; Ammerpohl, O.; Luttges, J.; Bohme, A.; Sipos, B.; Foerder, M.; Alldinger, I.; Jahnke, B.; Schackert, H.K.; Kalthoff, H.; Kremer, B.; Kloppel, G.; Saeger, H.D. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004, 6, 611-622.
30. Pilarsky, C.; Ammerpohl, O.; Sipos, B.; Dahl, E.; Hartmann, A.; Wellmann, A.; Braunschweig, T.; Lohr, M.; Jesnowski, R.; Friess, H.; Wente, M.N.; Kristiansen, G.; Jahnke, B.; Denz, A.; Ruckert, F.; Schackert, H.K.; Kloppel, G.; Kalthoff, H.; Saeger, H.D.; Grutzmann, R. Activation of wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J. Cell. Mol. Med. 2008, 12, 2823-2835.
31. Matsuzaki, H.; Schmied, B.M.; Ulrich, A.; Standop, J.; Schneider, M.B.; Batra, S.K.; Picha, K.S.; Pour, P.M. Combination of tumor necrosis factor-related apoptosis-inducing ligand (trail) and actinomycin d induces apoptosis even in trail-resistant human pancreatic cancer cells. Clin. Cancer Res. 2001, 7, 407-414.
32. Bai, J.; Sui, J.; Demirjian, A.; Vollmer, C.M., Jr.; Marasco, W.; Callery, M.P. Predominant bcl-xl knockdown disables antiapoptotic mechanisms: Tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res. 2005, 65, 2344-2352.
33. Baran, B.; Bechyne, I.; Siedlar, M.; Szpak, K.; Mytar, B.; Sroka, J.; Laczna, E.; Madeja, Z.; Zembala, M.; Czyz, J. Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: The role of tumour necrosis factor-alpha. Eur. J. Cell Biol. 2009, 88, 743-752.
34. Satoh, K.; Kaneko, K.; Hirota, M.; Masamune, A.; Satoh, A.; Shimosegawa, T. Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. Pancreas 2001, 23, 251-258.
35. Hinz, S.; Trauzold, A.; Boenicke, L.; Sandberg, C.; Beckmann, S.; Bayer, E.; Walczak, H.; Kalthoff, H.; Ungefroren, H. Bcl-xl protects pancreatic adenocarcinoma cells against cd95-and trail-receptor-mediated apoptosis. Oncogene 2000, 19, 5477-5486.
36. LeBlanc, H.N.; Ashkenazi, A. Apo2l/trail and its death and decoy receptors. Cell. Death Difer. 2003, 10, 66-75.
37. Westphal, S.; Kalthoff, H. Apoptosis: Targets in pancreatic cancer. Mol. Cancer 2003, 2, 6.
38. Adams, J.M.; Cory, S. Bcl-2-regulated apoptosis: Mechanism and therapeutic potential. Curr. Opin. Immunol. 2007, 19, 488-496.
39. Cory, S.; Adams, J.M. The bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2, 647-656.
40. Cory, S.; Huang, D.C.; Adams, J.M. The bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003, 22, 8590-8607.
41. Rodriguez, J.; Lazebnik, Y. Caspase-9 and apaf-1 form an active holoenzyme. Genes Dev. 1999, 13, 3179-3184.
42. Campioni, M.; Santini, D.; Tonini, G.; Murace, R.; Dragonetti, E.; Spugnini, E.P.; Baldi, A. Role of apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Exp. Dermatol. 2005, 14, 811-818.
43. Gerhard, M.C.; Schmid, R.M.; Hacker, G. Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br. J. Cancer 2002, 86, 893-898.
44. Vogler, M.; Durr, K.; Jovanovic, M.; Debatin, K.M.; Fulda, S. Regulation of trail-induced apoptosis by xiap in pancreatic carcinoma cells. Oncogene 2007, 26, 248-257.
45. Fulda, S. Inhibitor of apoptosis (iap) proteins: Novel insights into the cancer-relevant targets for cell death induction. ACS Chem. Biol. 2009, 4, 499-501.
46. Shiozaki, E.N.; Shi, Y. Caspases, iaps and smac/diablo: Mechanisms from structural biology. Trends Biochem. Sci. 2004, 29, 486-494.
47. Vaux, D.L.; Silke, J. Htra2/omi, a sheep in wolf's clothing. Cell 2003, 115, 251-253.
48. Tsujimoto, Y. Role of bcl-2 family proteins in apoptosis: Apoptosomes or mitochondria? Genes Cells 1998, 3, 697-707.
49. O'Neill, J.; Manion, M.; Schwartz, P.; Hockenbery, D.M. Promises and challenges of targeting bcl-2 anti-apoptotic proteins for cancer therapy. Biochim. Biophys. Acta 2004, 1705, 43-51.
50. Shi, X.; Liu, S.; Kleeff, J.; Friess, H.; Buchler, M.W. Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosisregulating genes. Oncology 2002, 62, 354-362.
51. Billen, L.P.; Shamas-Din, A.; Andrews, D.W. Bid: A bax-like bh3 protein. Oncogene 2008, 27 (Suppl. 1), S93-S104.
52. Bouillet, P.; Strasser, A. Bh3-only proteins-evolutionarily conserved proapoptotic bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 2002, 115, 1567-1574.
53. Tsujimoto, Y.; Finger, L.R.; Yunis, J.; Nowell, P.C.; Croce, C.M. Cloning of the chromosome breakpoint of neoplastic b cells with the t(14;18) chromosome translocation. Science 1984, 226, 1097-1099.
54. Tsujimoto, Y.; Croce, C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 1986, 83, 5214-5218.
55. Ghiotto, F.; Fais, F.; Bruno, S. Bh3-only proteins: The death-puppeteer's wires. Cytometry A 2010, 77, 11-21.
56. Evans, J.D.; Cornford, P.A.; Dodson, A.; Greenhalf, W.; Foster, C.S.; Neoptolemos, J.P. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 2001, 1, 254-262.
57. Ruckert, F.; Samm, N.; Lehner, A.K.; Saeger, H.D.; Grutzmann, R.; Pilarsky, C. Simultaneous gene silencing of bcl-2, xiap and survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010, 10, 379.
58. Green, D.R.; Reed, J.C. Mitochondria and apoptosis. Science 1998, 281, 1309-1312.
59. Campani, D.; Esposito, I.; Boggi, U.; Cecchetti, D.; Menicagli, M.; De Negri, F.; Colizzi, L.; Del Chiaro, M.; Mosca, F.; Fornaciari, G.; Bevilacqua, G. Bcl-2 expression in pancreas development and pancreatic cancer progression. J. Pathol. 2001, 194, 444-450.
60. Fritsch, R.M.; Schneider, G.; Saur, D.; Scheibel, M.; Schmid, R.M. Translational repression of mcl-1 couples stress-induced eif2 alpha phosphorylation to mitochondrial apoptosis initiation. J. Biol. Chem. 2007, 282, 22551-22562.
61. Finucane, D.M.; Bossy-Wetzel, E.; Waterhouse, N.J.; Cotter, T.G.; Green, D.R. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by bcl-xl. J. Biol. Chem. 1999, 274, 2225-2233.
62. Xu, Z.W.; Friess, H.; Buchler, M.W.; Solioz, M. Overexpression of bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. Cancer Chemot her. Pharmacol. 2002, 49, 504-510.
63. Graber, H.U.; Friess, H.; Zimmermann, A.; Korc, M.; Adler, G.; Schmid, R.; Buchler, M.W. Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells. J. Gastrointest. Surg. 1999, 3, 74-80.
64. Adachi, M.; Imai, K. The proapoptotic bh3-only protein bad transduces cell death signals independently of its interaction with bcl-2. Cell Death Difer. 2002, 9, 1240-1247.
65. Miyamoto, Y.; Hosotani, R.; Wada, M.; Lee, J.U.; Koshiba, T.; Fujimoto, K.; Tsuji, S.; Nakajima, S.; Doi, R.; Kato, M.; Shimada, Y.; Imamura, M. Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in pancreatic cancers. Oncology 1999, 56, 73-82.
66. Evan, G.I.; Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411, 342-348.
67. Ghavami, S.; Hashemi, M.; Ande, S.R.; Yeganeh, B.; Xiao, W.; Eshraghi, M.; Bus, C.J.; Kadkhoda, K.; Wiechec, E.; Halayko, A.J.; Los, M. Apoptosis and cancer: Mutations within caspase genes. J. Med. Genet. 2009, 46, 497-510.
68. Thornberry, N.A.; Lazebnik, Y. Caspases: Enemies within. Science 1998, 281, 1312-1316.
69. Ghavami, S.; Eshraghi, M.; Kadkhoda, K.; Mutawe, M.M.; Maddika, S.; Bay, G.H.; Wesselborg, S.; Halayko, A.J.; Klonisch, T.; Los, M. Role of bnip3 in tnf-induced cell death--tnf upregulates bnip3 expression. Biochim. Biophys. Acta 2009, 1793, 546-560.
70. Matsunaga, T.; Tsuji, Y.; Kaai, K.; Kohno, S.; Hirayama, R.; Alpers, D.H.; Komoda, T.; Hara, A. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: Implication in oxidative stress. Cancer Chemother. Pharmacol. 2010, 66, 517-526.
71. Huang, X.; Zhang, Z.; Jia, L.; Zhao, Y.; Zhang, X.; Wu, K. Endoplasmic reticulum stress contributes to vitamine succinate-induced apoptosis in human gastric cancer sgc-7901 cells. Cancer Lett. 2010, 296, 123-131.
72. Zou, H.; Henzel, W.J.; Liu, X.; Lutschg, A.; Wang, X. Apaf-1, a human protein homologous to c. Elegans ced-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90, 405-413.
73. Soung, Y.H.; Lee, J.W.; Kim, S.Y.; Park, W.S.; Nam, S.W.; Lee, J.Y.; Yoo, N.J.; Lee, S.H. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS 2006, 114, 292-297.
74. Kischkel, F.C.; Lawrence, D.A.; Tinel, A.; LeBlanc, H.; Virmani, A.; Schow, P.; Gazdar, A.; Blenis, J.; Arnott, D.; Ashkenazi, A. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 2001, 276, 46639-46646.
75. Soung, Y.H.; Lee, J.W.; Kim, S.Y.; Park, W.S.; Nam, S.W.; Lee, J.Y.; Yoo, N.J.; Lee, S.H. Somatic mutations of casp3 gene in human cancers. Hum. Genet. 2004, 115, 112-115.
76. Wyllie, A.H. Apoptosis and carcinogenesis. Eur. J. Cell Biol. 1997, 73, 189-197.
77. LaCasse, E.C.; Mahoney, D.J.; Cheung, H.H.; Plenchette, S.; Baird, S.; Korneluk, R.G. Iaptargeted therapies for cancer. Oncogene 2008, 27, 6252-6275.
78. Deveraux, Q.L.; Reed, J.C. Iap family proteins--suppressors of apoptosis. Genes Dev. 1999, 13, 239-252.
79. Galban, S.; Duckett, C.S. Xiap as a ubiquitin ligase in cellular signaling. Cell Death Difer. 2010, 17, 54-60.
80. Mohr, A.; Albarenque, S.M.; Deedigan, L.; Yu, R.; Reidy, M.; Fulda, S.; Zwacka, R.M. Targeting of xiap combined with systemic mesenchymal stem cell-mediated delivery of strail ligand inhibits metastatic growth of pancreatic carcinoma cells. Stem Cells 2010, 28, 2109-2120.
81. Eckelman, B.P.; Salvesen, G.S.; Scott, F.L. Human inhibitor of apoptosis proteins: Why xiap is the black sheep of the family. EMBO Rep. 2006, 7, 988-994.
82. Altieri, D.C. Survivin and iap proteins in cell-death mechanisms. Biochem. J. 2010, 430, 199-205.
83. Tamm, I.; Wang, Y.; Sausville, E.; Scudiero, D.A.; Vigna, N.; Oltersdorf, T.; Reed, J.C. Iap-family protein survivin inhibits caspase activity and apoptosis induced by fas (cd95), bax, caspases, and anticancer drugs. Cancer Res. 1998, 58, 5315-5320.
84. Altieri, D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 2003, 3, 46-54.
85. Satoh, K.; Kaneko, K.; Hirota, M.; Masamune, A.; Satoh, A.; Shimosegawa, T. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 2001, 92, 271-278.
86. Martinez-Ruiz, G.; Maldonado, V.; Ceballos-Cancino, G.; Grajeda, J.P.; Melendez-Zajgla, J. Role of smac/diablo in cancer progression. J. Exp. Clin. Cancer Res. 2008, 27, 48.
87. Verhagen, A.M.; Vaux, D.L. Cell death regulation by the mammalian iap antagonist diablo/smac. Apoptosis 2002, 7, 163-166.
88. Verhagen, A.M.; Ekert, P.G.; Pakusch, M.; Silke, J.; Connolly, L.M.; Reid, G.E.; Moritz, R.L.; Simpson, R.J.; Vaux, D.L. Identification of diablo, a mammalian protein that promotes apoptosis by binding to and antagonizing iap proteins. Cell 2000, 102, 43-53.
89. Kashkar, H.; Seeger, J.M.; Hombach, A.; Deggerich, A.; Yazdanpanah, B.; Utermohlen, O.; Heimlich, G.; Abken, H.; Kronke, M. Xiap targeting sensitizes hodgkin lymphoma cells for cytolytic t-cell attack. Blood 2006, 108, 3434-3440.
90. Kashkar, H.; Haefs, C.; Shin, H.; Hamilton-Dutoit, S.J.; Salvesen, G.S.; Kronke, M.; Jurgensmeier, J.M. Xiap-mediated caspase inhibition in hodgkin's lymphoma-derived b cells. J. Exp. Med. 2003, 198, 341-347.
91. Arnt, C.R.; Chiorean, M.V.; Heldebrant, M.P.; Gores, G.J.; Kaufmann, S.H. Synthetic smac/diablo peptides enhance the effects of chemotherapeutic agents by binding xiap and ciap1 in situ. J. Biol. Chem. 2002, 277, 44236-44243.
92. Azmi, A.S.; Wang, Z.; Philip, P.A.; Mohammad, R.M.; Sarkar, F.H. Emerging bcl-2 inhibitors for the treatment of cancer. Expert Opin. Emerg. Drugs. 2010, doi:10.1517/14728214.2010.515210.
93. Stadel, D.; Mohr, A.; Ref, C.; Macfarlane, M.; Zhou, S.; Humphreys, R.; Bachem, M.; Cohen, G.; Moller, P.; Zwacka, R.; Debatin, K.M.; Fulda, S. Trail-induced apoptosis is preferentially mediated via trail receptor 1 in pancreatic carcinoma cells and profoundly enhanced by xiap inhibitors. Clin. Cancer Res. 2010, 16, 5734-5749.